Atrial fibrillation (AF) is highly prevalent with a lifetime risk of about 1 in 3–5 individuals after
the age of 45 years. Between 2010 and 2019, the global prevalence of AF has risen …

Abstract Purpose of Review Atrial fibrillation (AF) and myocardial infarction (MI) often
coexist, and this overlapping nature leads to heightened morbidity and increases the need …

Objectives To examine how the lifetime risks of atrial fibrillation and of complications after
atrial fibrillation changed over time. Design Danish, nationwide, population based cohort …

Background The prevalence and impact of coronary emboli (CE) in patients with ST‐
segment–elevation myocardial infarction (STEMI) and atrial fibrillation (AF) have not been …

This article aims to analyze the relationship between non-obstructive coronary artery
disease (NOCAD) and atrial fibrillation (AF), exploring the underlying pathophysiological …

Background New-onset atrial fibrillation (NOAF) complicating ST-segment elevation
myocardial infarction (STEMI) remains clinically challenging. The aim of this study was to …

Introduction: Atrial fibrillation (AF) is a common arrhythmia, with radiofrequency catheter
ablation (RFCA) being first-line therapy. However, the high rate of post-ablation recurrence …

Background Evidence for the relationship between remnant cholesterol (RC) and incident
atrial fibrillation (AF) risk remains sparse and limited. Methods and Results Participants were …

Background Previous observational studies have documented an inverse association of
birthweight with myocardial infarction (MI) but a positive association with atrial fibrillation …

Background Individuals with both atrial fibrillation (AF) and myocardial infarction (MI) have
higher mortality compared with individuals with only 1 condition. Whether mortality differs …